[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB2144129B - Antigens as immunostimulant adjuvants - Google Patents

Antigens as immunostimulant adjuvants

Info

Publication number
GB2144129B
GB2144129B GB08423211A GB8423211A GB2144129B GB 2144129 B GB2144129 B GB 2144129B GB 08423211 A GB08423211 A GB 08423211A GB 8423211 A GB8423211 A GB 8423211A GB 2144129 B GB2144129 B GB 2144129B
Authority
GB
United Kingdom
Prior art keywords
antigens
immunostimulant
adjuvants
immunostimulant adjuvants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08423211A
Other versions
GB8423211D0 (en
GB2144129A (en
Inventor
Vilas V Likhite
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB08125792A external-priority patent/GB2104527B/en
Application filed by Individual filed Critical Individual
Priority to GB08423211A priority Critical patent/GB2144129B/en
Publication of GB8423211D0 publication Critical patent/GB8423211D0/en
Publication of GB2144129A publication Critical patent/GB2144129A/en
Application granted granted Critical
Publication of GB2144129B publication Critical patent/GB2144129B/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB08423211A 1981-08-24 1984-09-14 Antigens as immunostimulant adjuvants Expired GB2144129B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB08423211A GB2144129B (en) 1981-08-24 1984-09-14 Antigens as immunostimulant adjuvants

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB08125792A GB2104527B (en) 1981-08-24 1981-08-24 Antingens as immunostimulant adjuvants
GB08423211A GB2144129B (en) 1981-08-24 1984-09-14 Antigens as immunostimulant adjuvants

Publications (3)

Publication Number Publication Date
GB8423211D0 GB8423211D0 (en) 1984-10-17
GB2144129A GB2144129A (en) 1985-02-27
GB2144129B true GB2144129B (en) 1985-10-09

Family

ID=26280560

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08423211A Expired GB2144129B (en) 1981-08-24 1984-09-14 Antigens as immunostimulant adjuvants

Country Status (1)

Country Link
GB (1) GB2144129B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5445817A (en) * 1992-08-21 1995-08-29 The United States Of America As Represented By The Department Of Health And Human Services Pertussis toxin used as a carrier protein with non-charged saccharides in conjugate vaccines
US20030072774A1 (en) * 1994-06-10 2003-04-17 Diane M. Gajewczyk Proteinaceous adjuvants

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2461439C3 (en) * 1974-12-24 1980-03-20 Behringwerke Ag, 3550 Marburg Process for the preparation of a protective antigen from Bordetella pertussis and agent containing the same
FR2393065A1 (en) * 1977-05-31 1978-12-29 Merieux Inst PROCESS FOR SEPARATION OF LIPIDS FROM BACTERIAL ENDOTOXINS AND IN PARTICULAR FROM BORDETELLA PERTUSSIS ENDOTOXIN
US4247452A (en) * 1978-03-01 1981-01-27 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Purification of pertussis haemagglutinins

Also Published As

Publication number Publication date
GB8423211D0 (en) 1984-10-17
GB2144129A (en) 1985-02-27

Similar Documents

Publication Publication Date Title
GB2189143B (en) Immunological adjuvants for polysaccharide vaccines
IL70727A0 (en) Coupled h.influenzae type b vaccine
GB2095552B (en) Vaccines containing virus-saccharide conjugates
GB8324800D0 (en) Antigens
ZA811662B (en) Vaccine
GB8805233D0 (en) Vaccine against pasteurella
AU552702B2 (en) Synthetic vaccines
ZA844002B (en) Novel vaccines
GB2145419B (en) Vaccines
AU2549584A (en) Enhancing vaccines: antigenicity
AU557161B2 (en) Pseudorabies vaccine
AU522338B2 (en) Vaccine adjuvants
AU568820B2 (en) Vaccine against moraxella bovis
AU547725B1 (en) Brucellosis vaccine
GB2144129B (en) Antigens as immunostimulant adjuvants
AU7121281A (en) Chlamydous vaccine
GB2104527B (en) Antingens as immunostimulant adjuvants
GB2142334B (en) Immunogenic preparations
JPS5612320A (en) Immunity adjuvant
AU8592982A (en) Mastitis vaccine
IL65920A (en) Anti-brucellosis vaccine and its preparation
AU572178B2 (en) Vaccines with pseudo hepatitis-e/c antigens
IE811239L (en) Vaccine
ZA847914B (en) Vaccine
GB8302937D0 (en) Vaccine

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee